Insider · CIK 0001098972
Agenus Inc
Files at INKT (MiNK Therapeutics, Inc.). First filing Oct 16, 2023, latest Oct 16, 2023.
In brief
Agenus Inc files SEC Form 4 as 10% owner at INKT (MiNK Therapeutics, Inc.). Since Oct 16, 2023, Agenus Inc has reported 1 open-market buy worth $25k and 0 open-market sells worth $0, the latest filed on Oct 16, 2023.
A track record needs three past buys with six months of prices behind them; Agenus Inc has 0, so none is measured yet.
The newest scored trade: bought $25k of INKT on Oct 12, 2023, filed Oct 16, 2023, scored 15 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INKT: MiNK Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | INKTbuy MiNK Therapeutics, Inc. | $25k 22,975 shares | +0% | +30% from low-66% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 29, 2025 | INKT MiNK Therapeutics, Inc | 786,750 19.84% of outstanding | $13M | Aug 29, 2025 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 12, 2023 | INKT MiNK Therapeutics, Inc. | POpen-market purchase Common Stock | +3,173 | $1.10 | $3,488 | 21,753,061 | Oct 16, 2023 |
| Oct 13, 2023 | INKT MiNK Therapeutics, Inc. | POpen-market purchase Common Stock | +19,373 | $1.10 | $21k | 21,772,434 | Oct 16, 2023 |
| Oct 16, 2023 | INKT MiNK Therapeutics, Inc. | POpen-market purchase Common Stock | +429 | $1.10 | $472 | 21,772,863 | Oct 16, 2023 |
Questions about Agenus Inc
Answered from the filings on this page, as of the latest one.
Is Agenus Inc buying or selling?
Not in the last 12 months. Agenus Inc's latest open-market trade on SEC Form 4 was bought $25k of INKT on Oct 12, 2023.
How did Agenus Inc's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Agenus Inc has 0.
Where does Agenus Inc file Form 4?
Agenus Inc has filed Form 4 at INKT (MiNK Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.